Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC AND Treatment
3 results:

  • 1. Validation of Genetic Markers Associated with Survival in colorectal cancer Patients Treated with Oxaliplatin-Based Chemotherapy.
    Park HA; Seibold P; Edelmann D; Benner A; Canzian F; Alwers E; Jansen L; Schneider M; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):352-361. PubMed ID: 34862210
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab treatment in a Disseminated i.p. Tumor Model.
    Yong KJ; Milenic DE; Baidoo KE; Brechbiel MW
    PLoS One; 2016; 11(7):e0159904. PubMed ID: 27467592
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.
    Kap EJ; Seibold P; Richter S; Scherer D; Habermann N; Balavarca Y; Jansen L; Becker N; Pfütze K; Popanda O; Hoffmeister M; Ulrich A; Benner A; Ulrich CM; Burwinkel B; Brenner H; Chang-Claude J
    Pharmacogenomics J; 2015 Dec; 15(6):505-12. PubMed ID: 25778469
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.